8-K
filed May 7, 2026, 7:59 PM ET
ticker MD
CIK 0000893949
other material
confidence high
sentiment neutral
materiality 0.55
Pediatrix shareholders approve 8M share increase in incentive plan; director Starcher faces 36% withhold vote
Pediatrix Medical Group, Inc.
- Shareholders approved the Second Amended and Restated 2008 Incentive Compensation Plan, increasing authorized shares by 8,000,000.
- Director John M. Starcher, Jr. received 46,296,745 votes for (55%) and 25,909,618 against (36% of votes cast excluding broker non-votes).
- PricewaterhouseCoopers LLP ratified as auditor for 2026 with 75,519,473 for (97.6% of votes cast).
- Advisory vote on named executive officer compensation for 2025 approved with 70,257,832 for (97.3% of votes cast excluding broker non-votes).
- All other director nominees received over 98% support from votes cast.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Pediatrix Medical Group, Inc. shareholders approved Approval of the Second Amended and Restated 2008 Incentive Compensation Plan (increase in shares) at the 2026-05-07 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2026-05-07
Exact text from the filing
Proposal 4: The Plan was approved by the Company’s shareholders, by the votes set forth in the table below: For Against Abstained Broker Non-Vote 65,912,243 6,303,675 18,413 5,095,808
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Pediatrix Medical Group, Inc. shareholders approved Election of Directors at the 2026-05-07 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-07
Exact text from the filing
Proposal 1: All of the nominees for the Company’s Board of Directors were elected to serve until the Company’s 2027 Annual Shareholders’ Meeting or until their respective successors are elected and qualified, by the votes set forth in the table below: Name For Against Abstained Broker Non-Vote Laura A. Linynsky 71,249,187 967,057 18,087 5,095,808 Thomas A. McEachin 70,107,436 2,093,168 33,727 5,095,808 Kurt D. Newman, M.D. 71,922,039 256,292 56,000 5,095,808 Mark S. Ordan 69,958,141 2,259,130 17,060 5,095,808 Michael A. Rucker 70,689,577 1,523,843 20,911 5,095,808 Guy P. Sansone 70,738,837 1,475,369 20,125 5,095,808 John M. Starcher, Jr. 46,296,745 25,909,618 27,968 5,095,808 Shirley A. Weis 70,725,919 1,478,539 29,873 5,095,808 Sylvia J. Young 71,257,572 963,152 13,607 5,095,808
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Pediatrix Medical Group, Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2026 at the 2026-05-07 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-07
Exact text from the filing
Proposal 2: The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year was ratified by the Company’s shareholders, by the votes set forth in the table below: For Against Abstained Broker Non-Vote 75,519,473 1,794,278 16,388 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Pediatrix Medical Group, Inc. shareholders approved Advisory vote on executive compensation (say-on-pay) at the 2026-05-07 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-05-07
Exact text from the filing
Proposal 3: The Company’s shareholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers for the 2025 fiscal year, by the votes set forth in the table below: For Against Abstained Broker Non-Vote 70,257,832 1,960,931 15,568 5,095,808
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.